HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

You may also be interested in...



P&G Goes For Gold With 2012 Multi-Brand Olympic Sponsorship

P&G’s multi-brand commercial innovation strategy surrounding the 2012 Summer Olympics in London is expected to add $500 million in incremental sales, the Cincinnati-based marketer said at the Citi Global Consumer Conference May 23.

Physicians Formula Highlights Clinical Data Behind First National Skin-Care Line

As it enters the crowded skin-care market, Physicians Formula is counting on clinical trial results and efficacious ingredients highlighted on product packaging to distinguish its line from the competition.

With AE Reporting Push, FDA Emphasizes Importance Of Cosmetic Safety

FDA hopes a campaign promoting its adverse event reporting program for cosmetics will lead to increased consumer participation, which could put further pressure on industry to ensure the safety of their products.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel